SourcingAI
Try for free
Powered by Made-in-China.com
Reduced Glutathione for Injection with GMP 0.3/0.6/1.2g
US$44.30-53.48
7,500 Pieces
Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

For external use

Model NO.

0.3/0.6/1.2g

Suitable for

Elderly, Children, Adult

State

Solid

Shape

Oral Liquid

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

H20013187

Indate

3years

Sterile

Sterile

Color

White

Standard

Bp/Cp

Transport Package

50vials/Tray/Box, 20boxes/Carton

Specification

0.3/0.6/1.2g

Trademark

Reyoung

Origin

China

HS Code

3003101900

Production Capacity

20000000vials/Year

Key features

GMP and ISO Certified: Manufactured under GMP, ISO9001, and ISO14001 standards for quality assurance.
Multiple Dosage Options: Available in 0.3g, 0.6g, and 1.2g specifications for flexible usage.
Antioxidant and Detoxification: Helps maintain immune function and provides integrated detoxification effects.
Sterile and White: Product is sterile with a white color, meeting BP/CP standards.
OEM and ODM Services: Customization services available for branding and formulation needs.
Wide Application Scope: Suitable for elderly, children, and adults as a pharmaceutical or functional food base.
Experienced Manufacturer: Established in 1998 with 370 R&D engineers and extensive production capacity.
Global Export Capability: Exports to South America, Southeast Asia, Middle East, and Africa with FOB/CIF terms.

Company profile

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 1997-01-01 CertifiedNearest Port: Qingdao PortAverage Response Time: ≤18h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryREYOUNG PHARMACEUTICAL CO., LTD. is a China-based limited company established in 1998, with 4,950 employees and operations in Shandong. The supplier reports ISO 9001, ISO 14001, and OHSAS 18001 certifications, more than 10 production lines, 50 quality-control staff, and 370 years of combined R&D-engineer experience. Its stated manufacturing portfolio includes sterile raw materials, powders and liquids for injection, tablets, and capsules, with reported annual production above the stated threshold. The company identifies three factories, an extensive manufacturing area, international business since 1997, and export markets across South America, Africa, Southeast Asia, and the Middle East. Trade records show transactions involving India, Bolivia, and Vietnam, including cefotaxime-related products. Evidence is insufficient to assess after-sales service, financial credibility, innovation output, or customization capability. Customer-case evidence is limited to named buyers and trade records.
Supplier typeThe supplier is identified as a combined business entity and a limited company headquartered in Shandong, China. Its business scope is health and medicine, with products including sterile raw materials, injectable products, tablets, and capsules, supporting classification as a pharmaceutical manufacturer and distributor.
CertificationsThe supplier explicitly reports ISO 9001:2015, ISO 14001:2015, and OHSAS 18001:2007 certificates, and separately describes itself as GMP and ISO authenticated. These stated certifications provide direct evidence of formal quality, environmental, and occupational-health management systems.
Production capacityProduction capacity is supported by more than 10 production lines, three factories, a reported manufacturing area of 1,000,000 square meters, and stated annual output across small-volume injections, powder injections, tablets, and capsules. The supplier also reports annual production above the stated threshold, indicating substantial multi-form pharmaceutical manufacturing capability.
Client casesTrade records identify transactions involving STERILE INDIA PRIVATE LIMITED, HEREDIA ARACENA RENY EVELIN, and a Vietnam-related registration, with products including cefotaxime-related material and oral rehydration products. These records demonstrate some international commercial activity, but the evidence is limited and does not establish long-term customer performance or a broad verified customer portfolio.

Product Q&A

Q:What are the available specifications?
A:
The product is available in 0.3g, 0.6g, and 1.2g specifications.
Q:Is the product sterile?
A:
Yes, the product is sterile and meets BP/CP standards.
Q:What are the main functions of Reduced Glutathione?
A:
It helps maintain normal immune system function, acts as an antioxidant, and provides integrated detoxification effects.
Q:What are the potential adverse reactions?
A:
Possible reactions include mild oral mucosa white spots, ulcers, sudden rash, nausea, vomiting, and local pain upon injection. These usually disappear after stopping the drug.
Q:Can patients with Phenylketonuria use this product?
A:
Patients with Phenylketonuria should use this product with caution.

Send Inquiry

*To:REYOUNG PHARMACEUTICAL CO., LTD.REYOUNG PHARMACEUTICAL CO., LTD.
*Content:
0/4000

Supplier replies will be sent to your registered email

You may also like

High Quality Sodium Stannate Trihydrate
Made-in-China.com
High Quality Sodium Trimetaphosphate STMP CAS: 7785-84-4
Made-in-China.com
High Quality and High Performance Sodium Sulfite
Made-in-China.com
Facory Supplier Sodium Chloride Formate Ice -Melting
Made-in-China.com